Your browser doesn't support javascript.
loading
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
Mayer, Ingrid A; Prat, Aleix; Egle, Daniel; Blau, Sibel; Fidalgo, J Alejandro Pérez; Gnant, Michael; Fasching, Peter A; Colleoni, Marco; Wolff, Antonio C; Winer, Eric P; Singer, Christian F; Hurvitz, Sara; Estévez, Laura García; van Dam, Peter A; Kümmel, Sherko; Mundhenke, Christoph; Holmes, Frankie; Babbar, Naveen; Charbonnier, Laure; Diaz-Padilla, Ivan; Vogl, Florian D; Sellami, Dalila; Arteaga, Carlos L.
Afiliación
  • Mayer IA; Department of Medicine, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. carlos.arteaga@utsouthwestern.edu ingrid.mayer@vumc.org.
  • Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Egle D; Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria.
  • Blau S; Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington.
  • Fidalgo JAP; Department of Oncology, CIBERONC, Hospital Clínico Universitario de Valencia - INCLIVA, Valencia, Spain.
  • Gnant M; Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen and Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Erlangen, Germany.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology (IEO), IRCCS, Milan, and International Breast Cancer Study Group, Milan, Italy.
  • Wolff AC; Department of Oncology, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Hurvitz S; Department of Medicine, University of California, Los Angeles, California.
  • Estévez LG; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • van Dam PA; Gynecologic Oncology and Senology, Antwerp University Hospital, Edegem, Belgium.
  • Kümmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
  • Mundhenke C; Department of Obstetrics and Gynecology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
  • Holmes F; Texas Oncology-Houston Memorial City and US Oncology Research Network, Houston, Texas.
  • Babbar N; Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Charbonnier L; Statistics, Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Diaz-Padilla I; Oncology Global Development, Novartis Pharma AG, Basel, Switzerland.
  • Vogl FD; Oncology Global Development, Novartis Pharma AG, Basel, Switzerland.
  • Sellami D; Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Arteaga CL; Department of Medicine, UTSW Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas. carlos.arteaga@utsouthwestern.edu ingrid.mayer@vumc.org.
Clin Cancer Res ; 25(10): 2975-2987, 2019 05 15.
Article en En | MEDLINE | ID: mdl-30723140
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos